4.6 Article

Novel Disulfiram Derivatives as ALDH1a1-Selective Inhibitors

Related references

Note: Only part of the references are listed.
Review Chemistry, Medicinal

Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors

Bingyan Li et al.

Summary: ALDH1A1, an important member of the ALDH family, plays crucial roles in physiology and pathology, especially in cancer, obesity, diabetes, and inflammation. Inhibition of ALDH1A1 may offer new therapeutic options for these diseases, and many inhibitors have been identified and developed.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Cell Biology

Aldehyde dehydrogenase 1A1 and 1A3 isoforms-mechanism of activation and regulation in cancer

M. Poturnajova et al.

Summary: The review summarizes the role of ALDH in solid tumors, particularly the ALDH1A1 and ALDH1A3 isoforms, including their transcription and regulation mechanisms, as well as their crosstalk with main molecular pathways. Additionally, it discusses the regulatory effect of lnRNA on ALDH1A1 and ALDH1A3.

CELLULAR SIGNALLING (2021)

Article Chemistry, Medicinal

Development of new disulfiram analogues as ALDH1a1-selective inhibitors

Ziad Omran

Summary: Disulfiram is a drug approved by the FDA for treating chronic alcoholism, acting by inhibiting ALDH2. It also inhibits ALDH1a1, a key therapeutic target for diseases like cancer and obesity. The study successfully synthesized a derivative, 2b, which showed comparable activity to Disulfiram against ALDH1a1 but no inhibitory activity against ALDH2.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)

Article Biochemistry & Molecular Biology

New Disulfiram Derivatives as MAGL-Selective Inhibitors

Ziad Omran

Summary: Novel disulfiram derivatives were evaluated as potent inhibitors of MAGL, showing high selectivity over FAAH. Compound 2i displayed low micromolar inhibition of MAGL without inhibitory activity against FAAH.

MOLECULES (2021)

Article Endocrinology & Metabolism

Repurposing Disulfiram as an Anti-Obesity Drug: Treating and Preventing Obesity in High-Fat-Fed Rats

Ziad Omran et al.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)

Review Pharmacology & Pharmacy

An Updated Review of Disulfiram: Molecular Targets and Strategies for Cancer Treatment

Qingzhu Yang et al.

CURRENT PHARMACEUTICAL DESIGN (2019)

Review Cell & Tissue Engineering

Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells

Giuseppe Vassalli

STEM CELLS INTERNATIONAL (2019)

Article Chemistry, Medicinal

Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives

Cameron D. Buchman et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Review Biochemistry & Molecular Biology

Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress

Surendra Singh et al.

FREE RADICAL BIOLOGY AND MEDICINE (2013)

Article Endocrinology & Metabolism

Retinaldehyde Dehydrogenase 1 Coordinates Hepatic Gluconeogenesis and Lipid Metabolism

Florian W. Kiefer et al.

ENDOCRINOLOGY (2012)

Article Biochemistry & Molecular Biology

Retinaldehyde represses adipogenesis and diet-induced obesity

Ouliana Ziouzenkova et al.

NATURE MEDICINE (2007)

Article Pharmacology & Pharmacy

Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism

V Vasiliou et al.

DRUG METABOLISM REVIEWS (2004)

Article Biochemistry & Molecular Biology

In vivo inhibition of aldehyde dehydrogenase by disulfiram

JJ Lipsky et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2001)